Showing results (701-710 of 5,007) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|August 8, 2006
The case for case reports: avoiding statistical seductionA Robert Kagan, Raoul J Burchette, Shawn Iganej
American Journal of Clinical Oncology|August 8, 2006
Same day Pegfilgrastim and CHOP chemotherapy for non-Hodgkin lymphomaJacob J Lokich
American Journal of Clinical Oncology|August 8, 2006
Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)Luigi Cavanna, Fabrizio Artioli, Claudio Codignola, et al.
American Journal of Clinical Oncology|August 8, 2006
Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I studyTom Dipetrillo, Luka Milas, Devon Evans, et al.
American Journal of Clinical Oncology|August 8, 2006
Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodesNicola Battelli, Cristian Massacesi, Chiara Braconi, et al.
American Journal of Clinical Oncology|August 8, 2006
Angiogenesis in colorectal cancer: prognostic and therapeutic implicationsAlexandra Giatromanolaki, Efthimios Sivridis, Michael I Koukourakis
American Journal of Clinical Oncology|June 1, 1990
Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient groupJ J Lokich
American Journal of Clinical Oncology|October 1, 1991
Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb)N K Zatopek, P Y Holoye, N A Ellerbroek, et al.
American Journal of Clinical Oncology|June 1, 1991
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group StudyD D Von Hoff, S Green, D S Alberts, et al.
American Journal of Clinical Oncology|February 7, 2007
Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancerMark I Hunter, Argyios Ziogas, Francisca Flores, et al.
Pageof 501